Related Experiment Videos
In vivo recombination of pseudorabies virus strains in mice
K L Glazenburg1, R J Moormann, T G Kimman
1Institute for Animal Science and Health (ID-DLO), Department of Virology, Lelystad, The Netherlands.
Abstract:
We studied in vivo recombination of pseudorabies virus (PRV) by inoculating mice with non-lethal mutants that carry a small deletion or insertion in the thymidine kinase (TK) gene or the ribonucleotide reductase (RR) gene. After co-inoculation of mice with two different mutants, homologous recombination between the viral genomes resulted in the generation of wild-type PRV that was highly lethal for mice. Thus, recombination could easily be assessed by monitoring survival of inoculated animals. Our results demonstrated that recombination was only detectable when high doses of virus were used. Intragenic recombination was more efficient between mutations in the TK gene than between mutations in the RR gene. Efficient intragenic recombination in the TK gene occurred between mutations which were separated by as few as 266 nucleotides. When two mutants were inoculated with an interval of 2 h, recombination still occurred. No recombination could be detected when the viruses were inoculated at the same time but in separate parts of the body. When inoculated separately, none of the mutants tested could be isolated from the brains of mice. Virus could be recovered from the brain, however, after co-inoculation. Surprisingly, of these viruses 36-39% possessed the parental mutant genotype. This observation indicates that complementation enables these mutants to replicate in the brain and suggests that complementation may contribute to pathogenicity of PRV.
Insights
In vivo recombination of pseudorabies virus (PRV) mutants generated lethal wild-type PRV in mice. Recombination efficiency depended on viral dose and gene location, with TK gene mutations recombining more readily.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Pseudorabies virus (PRV) is an important animal pathogen.
- Understanding viral recombination is crucial for controlling viral diseases.
- Viral gene function and interaction can be studied through recombination assays.
Purpose of the Study:
- To investigate in vivo recombination of PRV mutants.
- To assess the factors influencing PRV recombination efficiency.
- To evaluate the role of recombination and complementation in PRV pathogenicity.
Main Methods:
- Mice were inoculated with non-lethal PRV mutants with deletions/insertions in thymidine kinase (TK) or ribonucleotide reductase (RR) genes.
- Co-inoculation of different mutants allowed assessment of homologous recombination by monitoring animal survival.
- Viral recovery from brains was performed after different inoculation strategies.
Main Results:
- Homologous recombination between PRV mutants generated lethal wild-type virus, detectable by mouse survival.
- Recombination was observed only at high viral doses and was more efficient between TK gene mutations.
- Recombination occurred even with a 2-hour inoculation interval, and viruses were recovered from brains only after co-inoculation.
Conclusions:
- In vivo recombination of PRV can generate virulent strains.
- Complementation allows PRV mutants to replicate in the brain, potentially contributing to pathogenicity.
- Viral dose and specific gene mutations significantly impact recombination rates.